International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5
Original Research Article
A Comparative Longitudinal Study On Changes In Corneal Endothelial Cell Count And Central Corneal Thickness In Patients With And Without Diabetes Mellitus After Manual Small Incision Cataract Surgery In A Tertiary Care Centre In Mandya
Published
Oct. 29, 2024
Abstract

Background: Diabetes mellitus may affect corneal endothelial health, potentially impacting outcomes of cataract surgery.Objective: To compare changes in corneal endothelial cell count and central corneal thickness (CCT) after manual small incision cataract surgery (SICS) in patients with and without diabetes.Methods: This prospective study included 50 diabetic and 50 non-diabetic patients undergoing manual SICS. Corneal endothelial cell density and CCT were measured preoperatively and at day 1, week 1, and month 1 postoperatively. Results: At one month post-surgery, diabetic patients showed significantly greater endothelial cell loss (14.6% vs. 10.3%, p=0.003) and CCT increase (2.2% vs. 1.1%, p=0.025) compared to non-diabetic patients. Age (β=-5.2, p=0.004), presence of diabetes (β=-78.3, p=0.002), and HbA1c levels (β=-28.7, p=0.012) were significant predictors of endothelial cell loss. Visual acuity outcomes were similar between groups (0.18 ± 0.12 vs. 0.15 ± 0.10 logMAR, p=0.161), but diabetic patients showed a trend towards more complications. Conclusion: Diabetic patients experience greater corneal endothelial cell loss and increased CCT following manual SICS compared to non-diabetic patients. These findings highlight the need for careful consideration of diabetes in preoperative assessment and postoperative management of cataract surgery patients.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
1538 Views
146 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved